5 research outputs found
The Effect of a Mediterranean Diet on the Incidence of Cataract Surgery
Background: Cataract is a leading cause of vision impairment worldwide, and surgery
is the only available treatment. The process that initiates lens opacification is dependent on the
oxidative stress experienced by the lens components. A healthy overall dietary pattern, with the
potential to reduce oxidative stress, has been suggested as a means to decrease the risk of developing
cataract. We aimed to investigate the hypothesis that an intervention with a Mediterranean diet
(MedDiet) rather than a low-fat diet could decrease the incidence of cataract surgery in elderly subjects.
Methods: We included 5802 men and women (age range: 55–80 years) from the Prevención con
Dieta Mediterránea study (multicenter, parallel-group, randomized controlled clinical trial) who had not undergone cataract surgery. They were randomly assigned to one of three intervention groups:
(1) a MedDiet enriched with extra-virgin olive oil (EVOO) (n = 1998); (2) a MedDiet enriched with
nuts (n = 1914), and a control group recommended to follow a low-fat diet (n = 1890). The incidence
of cataract surgery was recorded yearly during follow-up clinical evaluations. Primary analyses
were performed on an intention-to-treat basis. Cox regression analyses were used to assess the
relationship between the nutritional intervention and the incidence of cataract surgery. Results:
During a follow-up period of 7.0 years (mean follow-up period: 5.7 years; median: 5.9 years),
559 subjects underwent cataract surgery. Two hundred and six participants from the MedDiet + EVOO
group, 174 from the MedDiet + Nuts group, and 179 from the control group underwent cataract
surgery. We did not observe a reduction in the incidence of cataract surgery in the MedDiet groups
compared to the control group. The multivariable adjusted hazard ratios were 1.03 (95% confidence
interval [CI]: 0.84–1.26, p = 0.79) for the control group versus the MedDiet + EVOO group and
1.06 (95% CI: 0.86–1.31, p = 0.58) for the control group versus the MedDiet + Nuts group. Conclusions:
To our knowledge, this is the first large randomized trial assessing the role of a MedDiet on the
incidence of cataract surgery. Our results showed that the incidence of cataract surgery was similar in
the MedDiet with EVOO, MedDiet with nuts, and low-fat diet groups. Further studies are necessary
to investigate whether a MedDiet could have a preventive role in cataract surgery
Patterns of Gene Expression and a Transactivation Function Exhibited by the vGCR (ORF74) Chemokine Receptor Protein of Kaposi's Sarcoma-Associated Herpesvirus
The ORF74 or vGCR gene encoded by Kaposi's sarcoma-associated herpesvirus (KSHV; also called human herpesvirus 8) has properties of a ligand-independent membrane receptor signaling protein with angiogenic properties that is predicted to play a key role in the biology of the virus. We have examined the expression of vGCR mRNA and protein in primary effusion lymphoma (PEL) cell lines, PEL and multicentric Castleman's disease (MCD) tumors, Kaposi's sarcoma lesions and infected endothelial cell cultures. The vGCR gene proved to be expressed in PEL cell lines as a large spliced bicistronic mRNA of 3.2 kb that also encompasses the upstream vOX2 (K14) gene. This mRNA species was induced strongly by phorbol ester (TPA) and sodium butyrate treatment in the BCBL-1 cell line, but only weakly in the HBL6 cell line, and was classified as a relatively late and low-abundance delayed early class lytic cycle gene product. A complex bipartite upstream lytic cycle promoter for this mRNA was nestled within the intron of the 5′-overlapping but oppositely oriented latent-state transcription unit for LANA1/vCYC-D/vFLIP and responded strongly to both TPA induction and cotransfection with the KSHV RNA transactivator protein (RTA or ORF50) in transient reporter gene assays. A vGCR protein product of 45 kDa that readily dimerized was detected by Western blotting and in vitro translation and was localized in a cytoplasmic and membrane pattern in DNA-transfected Vero and 293T cells or adenovirus vGCR-transduced dermal microvascular endothelial cells (DMVEC) as detected by indirect immunofluorescence assay (IFA) and immunohistochemistry with a specific rabbit anti-vGCR antibody. Similarly, a subfraction of KSHV-positive cultured PEL cells and of KSHV (JSC-1) persistently infected DMVEC cells displayed cytoplasmic vGCR protein expression, but only after TPA or spontaneous lytic cycle induction, respectively. The vGCR protein was also detectable by immunohistochemical staining in a small fraction (0.5 to 3%) of the cells in PEL and MCD tumor and nodular Kaposi's sarcoma lesion specimens that were apparently undergoing lytic cycle expression. These properties are difficult to reconcile with the vGCR protein's playing a direct role in spindle cell proliferation, transformation, or latency, but could be compatible with proposed contributions to angiogenesis via downstream paracrine effects. The ability of vGCR to transactivate expression of both several KSHV promoter-driven luciferase (LUC) reporter genes and an NFκB motif containing the chloramphenicol acetyltransferase (CAT) reporter gene may also suggest an unexpected regulatory role in viral gene expression
Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules:Clustering patterns, novel variants and chimerism
Background: the genomes of human Kaposi's sarcoma-associated herpesvirus (KSHV) display several levels of DNA sequence heterogeneity and subgrouping that show distinctive clustering patterns in related human populations. The four major subtype patterns for the hypervariable ORF-K1 protein correlate closely with the principal diasporas resulting from the migration of modern humans out of East Africa and suggest that KSHV is an ancient human virus that is transmitted primarily in a familial fashion with consequent very low recombination rates. However, chimeric genomes have also been detected, especially with regard to the presence of P versus M alleles of the ORF-K15 gene. Objectives: to understand further the genetic organization and evolutionary history of KSHV, especially with regard to possible new subtypes, recombinant genomes, constant region loci and clustering in particular ethnic groups or among classic versus epidemic cases in the same geographic area. Stitch, design: direct PCR DNA sequencing was carried out on the ORF-K1 and ORF-K15 genes at the extreme left and right hand sides, as well as on six other internal loci of diagnostic samples collected from 70 new KSHV-positive patients in Israel, South Korea, Sicily, Scandinavia, Brazil, Uganda, South Africa and the US. Results and conclusions: our overall results from more than 135 KSHV genomes from many different human population groups now provides evidence for seven distinct subtypes of KSHV genomes (referred to as A/P, B/P, C/P, D/P, M, N and Q). However, the two most closely related subtypes (A/P and C/P) are only differentiated at the LHS side of the genome, and the three most distantly related forms (M, N and Q) appear to exist only as small chimeric segments that are remnants from the RHS of more ancient forms of the virus. By analyzing multiple conserved loci across the B subtype genomes that predominate in sub-Saharan Africa, we can also now recognize three to four distinct B genome subgroups with varying patterns of inter and intratypic mosaicism. Analysis of classic KSHV genomes from Israel has revealed that the ORF-K1 clade referred to as Al' predominates in Ashkenazi Jewish immigrants from Russia, whereas C2 and C6 variants predominate in North African Sephardi Jews. A variety of chimeric genomes containing C2 or C3 ORF-K genes are disseminated among classic KS cases throughout Europe and Asia including Israel, Sicily, Scandinavia, South Korea, and Taiwan. Comparison of the genomes from classic versus AIDS-associated KSHV in the US indicates that it was derived originally by reactivation and spread of a subset of the endogenous viruses carried by descendants of immigrants from endemic areas of Northern and Eastern Europe, the Mediterranean and sub-Saharan Africa. (C) 2002 Elsevier Science B.V. All rights reserved
The Effect of a Mediterranean Diet on the Incidence of Cataract Surgery
Background: Cataract is a leading cause of vision impairment worldwide, and surgery
is the only available treatment. The process that initiates lens opacification is dependent on the
oxidative stress experienced by the lens components. A healthy overall dietary pattern, with the
potential to reduce oxidative stress, has been suggested as a means to decrease the risk of developing
cataract. We aimed to investigate the hypothesis that an intervention with a Mediterranean diet
(MedDiet) rather than a low-fat diet could decrease the incidence of cataract surgery in elderly subjects.
Methods: We included 5802 men and women (age range: 55–80 years) from the Prevención con
Dieta Mediterránea study (multicenter, parallel-group, randomized controlled clinical trial) who had not undergone cataract surgery. They were randomly assigned to one of three intervention groups:
(1) a MedDiet enriched with extra-virgin olive oil (EVOO) (n = 1998); (2) a MedDiet enriched with
nuts (n = 1914), and a control group recommended to follow a low-fat diet (n = 1890). The incidence
of cataract surgery was recorded yearly during follow-up clinical evaluations. Primary analyses
were performed on an intention-to-treat basis. Cox regression analyses were used to assess the
relationship between the nutritional intervention and the incidence of cataract surgery. Results:
During a follow-up period of 7.0 years (mean follow-up period: 5.7 years; median: 5.9 years),
559 subjects underwent cataract surgery. Two hundred and six participants from the MedDiet + EVOO
group, 174 from the MedDiet + Nuts group, and 179 from the control group underwent cataract
surgery. We did not observe a reduction in the incidence of cataract surgery in the MedDiet groups
compared to the control group. The multivariable adjusted hazard ratios were 1.03 (95% confidence
interval [CI]: 0.84–1.26, p = 0.79) for the control group versus the MedDiet + EVOO group and
1.06 (95% CI: 0.86–1.31, p = 0.58) for the control group versus the MedDiet + Nuts group. Conclusions:
To our knowledge, this is the first large randomized trial assessing the role of a MedDiet on the
incidence of cataract surgery. Our results showed that the incidence of cataract surgery was similar in
the MedDiet with EVOO, MedDiet with nuts, and low-fat diet groups. Further studies are necessary
to investigate whether a MedDiet could have a preventive role in cataract surgery